Lecithin/chitosan nanoparticles for transdermal delivery of melatonin

References

• Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Controlled Release 2006; 111: 107–16
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJ, Jiskoot W. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model. Vaccine 2007; 25: 144–53
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010; 56: 290–9
   PubMed Web of Science ®Google Scholar
• Bjorklund S, Engblom J, Thuresson K, Sparr E. A water gradient can be used to regulate drug transport across skin. J Controlled Release 2010; 143: 191–200
   PubMed Web of Science ®Google Scholar
• CarrenoGomez B, Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997; 148: 231–40
   Web of Science ®Google Scholar
• Ceraulo L, Fanara S, Liverib VT, Ruggirello A, Panzeri W, Mele A. Orientation and molecular contacts of melatonin confined into AOT and lecithin reversed micellar systems. Colloids Surf A 2008; 316: 307–12
   Google Scholar
• Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Delivery Rev 2004; 56: 675–711
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Controlled Release 2010; 141: 277–99
   PubMed Web of Science ®Google Scholar
• Chae SY, Jang MK, Nah JW. Influence of molecular weight on oral absorption of water soluble chitosans. J Controlled Release 2005; 102: 383–94
   PubMed Web of Science ®Google Scholar
• Dreher F, Denig N, Gabard B, Schwindt DA, Maibach HI. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology 1999; 198: 52–5
   Google Scholar
• Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 1998; 139: 332–9
   PubMed Web of Science ®Google Scholar
• Dreher F, Maibach H. Protective effects of topical antioxidants in humans. Curr Probl Dermatol 2001; 29: 157–64
   PubMedGoogle Scholar
• Dubey V, Mishra D, Asthana A, Jain NK. Transdermal delivery of a pineal hormone: Melatonin via elastic liposomes. Biomaterials 2006; 27: 3491–6
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Jain NK. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 2007; 67: 398–405
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Nahar M, Jain NK. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: Preparation, characterization and in vitro human skin transport study. Curr Drug Deliv 2008; 5: 199–206
   PubMedGoogle Scholar
• Gerelli Y, Barbieri S, Di Bari MT, Deriu A, Cantu L, Brocca P, Sonvico F, Colombo P, May R, Motta S. Structure of self-organized multilayer nanoparticles for drug delivery. Langmuir 2008; 24: 11378–84
   PubMedGoogle Scholar
• Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J. Melatonin-loaded lecithin/chitosan nanoparticles: Physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm 2009; 381: 205–13
   PubMed Web of Science ®Google Scholar
• He W, Guo X, Xiao L, Feng M. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int J Pharm 2009; 382: 234–43
   PubMed Web of Science ®Google Scholar
• He W, Guo X, Zhang M. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int J Pharm 2008; 356: 82–7
   PubMed Web of Science ®Google Scholar
• Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, Sterry W, Lademann J. Porcine ear skin: An in vitro model for human skin. Skin Res Technol 2007; 13: 19–24
   PubMed Web of Science ®Google Scholar
• Kanikkannan N, Jackson T, Shaik MS, Singh M. Evaluation of skin sensitization potential of melatonin and nimesulide by murine local lymph node assay. Eur J Pharm Sci 2001; 14: 217–20
   PubMedGoogle Scholar
• Kelmann RG, Kuminek G, Teixeira HF, Koester LS. Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int J Pharm 2007; 342: 231–9
   PubMed Web of Science ®Google Scholar
• Lee PW, Hsu SH, Tsai JS, Chen FR, Huang PJ, Ke CJ, Liao ZX, Hsiao CW, Lin HJ, Sung HW. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking. Biomaterials 2010; 31: 2425–34
   PubMed Web of Science ®Google Scholar
• Lorenz M, Saretzki G, Sitte N, Metzkow S, von Zglinicki T. BJ fibroblasts display high antioxidant capacity and slow telomere shortening independent of hTERT transfection. Free Radic Biol Med 2001; 31: 824–31
   PubMedGoogle Scholar
• Ong SY, Wu J, Moochhala SM, Tan MH, Lu J. Development of a chitosan-based wound dressing with improved haemostatic and antimicrobial properties. Biomaterials 2008; 29: 4323–32
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Aumklad P, Kowapradit J, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Puttipipatkhachorn S. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2). Pharm Dev Technol 2007; 12: 447–55
   PubMed Web of Science ®Google Scholar
• Pavelić Z, Škalko-Basnet N, Filipović-Grčić J, Martinac A, Jalšenjak I. Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Controlled Release 2005; 106: 34–43
   PubMed Web of Science ®Google Scholar
• Priano L, Esposti D, Esposti R, Castagna G, De Medici C, Fraschini F, Gasco MR, Mauro A. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J Nanosci Nanotechnol 2007; 7: 3596–601
   PubMed Web of Science ®Google Scholar
• Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE. Permeation enhancer effect of chitosan and chitosan derivatives: Comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 2008; 70: 270–8
   PubMed Web of Science ®Google Scholar
• Santander-Ortega MJ, Stauner T, Loretz B, Ortega-Vinuesa JL, Bastos-Gonzalez D, Wenz G, Schaefer UF, Lehr CM. Nanoparticles made from novel starch derivatives for transdermal drug delivery. J Controlled Release 2010; 141: 85–92
   PubMed Web of Science ®Google Scholar
• Schaffazick SR, Pohlmann AR, de Cordova CA, Creczynski-Pasa TB, Guterres SS. Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int J Pharm 2005; 289: 209–13
   PubMedGoogle Scholar
• Schaffazick SR, Siqueira IR, Badejo AS, Jornada DS, Pohlmann AR, Netto CA, Guterres SS. Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 2008; 69: 64–71
   PubMed Web of Science ®Google Scholar
• Schubert MA, Harms M, Muller-Goymann CC. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci 2006; 27: 226–36
   PubMed Web of Science ®Google Scholar
• Sekkat N, Kalia YN, Guy RH. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci 2002; 91: 2376–81
   PubMed Web of Science ®Google Scholar
• Senyigit T, Sonvico F, Barbieri S, Ozer O, Santi P, Colombo P. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Controlled Release 2010; 142: 368–73
   PubMed Web of Science ®Google Scholar
• Sheihet L, Chandra P, Batheja P, Devore D, Kohn J, Michniak B. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int J Pharm 2008; 350: 312–9
   PubMed Web of Science ®Google Scholar
• Singla AK, Chawla M. Chitosan. Some pharmaceutical and biological aspects – an update. J Pharm Pharmacol 2001; 53: 1047–67
   PubMed Web of Science ®Google Scholar
• Sonvico F, Cagnani A, Rossi A, Motta S, Di Bari MT, Cavatorta F, Alonso MJ, Deriu A, Colombo P. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction. Int J Pharm 2006; 324: 67–73
   PubMed Web of Science ®Google Scholar
• Tursilli R, Casolari A, Iannuccelli V, Scalia S. Enhancement of melatonin photostability by encapsulation in lipospheres. J Pharm Biomed Anal 2006; 40: 910–4
   PubMed Web of Science ®Google Scholar
• Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Delivery Rev 2001; 52: 105–15
   PubMed Web of Science ®Google Scholar
• Unfried K, Albrecht C, Klotz LO, Von Mikecz A, Grether-Beck S, Schins RPF. Cellular responses to nanoparticles: Target structures and mechanisms. Nanotoxicology 2007; 1: 52–71
   Web of Science ®Google Scholar
• Wiegand C, Hipler UC. Evaluation of biocompatibility and cytotoxicity using keratinocyte and fibroblast cultures. Skin Pharmacol Physiol 2009; 22: 74–82
   PubMed Web of Science ®Google Scholar
• Wiegand C, Winter D, Hipler UC. Molecular-weight-dependent toxic effects of chitosans on the human keratinocyte cell line HaCaT. Skin Pharmacol Physiol 2010; 23: 164–70
   PubMed Web of Science ®Google Scholar
• Williams A. Transdermal and topical drug delivery. Pharmaceutical Press, London 2003
   Google Scholar